share_log

諾誠健華-B:自願公告 根據博鰲樂城的先行項目開出TAFASITAMAB第一個處方,與來那度胺聯合用於治療複發及難治性瀰漫性大B細胞淋巴瘤

INNOCARE-B: VOLUNTARY ANNOUNCEMENT ON FIRST PRESCRIPTION OF TAFASITAMAB IN COMBINATION WITH LENALIDOMIDE FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA UNDER BOAO HOPE CITY''S EARLY ACCESS PROGRAM

Jul 21, 2022 20:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more